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Treatments for common and plantar warts
Salicylic acid or liquid nitrogen is probably no more effective than a wait and see policy
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Cutaneous warts are common, benign, and usually self limiting
papillomas.1 2 They present in various forms and sizes and are
caused by infection with human papillomavirus (HPV).1 2 The
twomost common types are common warts (verrucae vulgaris),
which usually occur on the hands, and plantar warts (verrucae
plantares), which are usually found on the soles of the feet.
Between 10% and 30% of primary school children have
cutaneous warts, of which two thirds resolve within two years.3
In the linked randomised controlled trial (doi:10.1136/bmj.
d3271), Cockayne and colleagues compare the effectiveness of
cryotherapy versus salicylic acid for the treatment of plantar
warts.4
Treatments have been based on destruction (cryotherapy,
photodynamic treatment, pulsed dye laser), keratolysis (salicylic
acid), immunostimulation (dinitrochlorobenzene, interferons),
or antimitotic effects (bleomycin, fluorouracil).1 5 A systematic
review of topical treatments for cutaneous warts was published
in 2006 and updated in 2009 to include subsequent randomised
controlled trials.5 6 The authors identified 78 relevant studies,
most of which were of low methodological quality, and
concluded that the only evidence based treatments were salicylic
acid and aggressive cryotherapy.5 In practice, many warts will
need a combination of treatments.7 Also, because most
modalities are user dependent, individual practitioners may have
higher or lower success rates than that reported in the literature.7
A subsequent randomised controlled trial of 250 participants in
primary care compared cryotherapy with liquid nitrogen every
two weeks, self application of salicylic acid daily, or a wait and
see approach. It found that cryotherapy was the most effective
treatment for common warts but found no clinically relevant
difference between the three approaches for plantar warts after
13 weeks.8
Cockayne and colleagues’ study investigated 240 patients aged
12 years or more with plantar warts.4 In one group of patients,
a healthcare professional delivered cryotherapy using liquid
nitrogen two to three weeks apart for a maximum of four
treatments. This treatment was compared with daily self
treatment with 50% salicylic acid for amaximum of eight weeks.
The trial found no significant difference in the proportions of
participants with complete clearance of all plantar warts at 12
weeks between the salicylic acid and cryotherapy groups (14.3%
v 13.6% clearance).4 Although no group was allocated to a wait
and see approach, the cure rates after intervention are probably
not higher than without intervention, as was found in the
previous trial.8
The patients in Cockayne and colleagues’ study were 12 years
or more, whereas the incidence of warts is highest in those aged
5-14.9 The low clearance rates they found are probably not
applicable to patients under 12 years because plantar warts in
children are less persistent than in adolescents and adults.8
Spontaneous clearance rates aremuch higher in younger children
than in those aged 12 years or more, and cryotherapy and
salicylic acid are not more effective than a wait and see
approach.8Although it may be best not to treat cutaneous warts,
some cases may warrant treatment, such as those associated
with considerable social stigma, especially when lesions are on
the face and hands.5 Warts that cause pain, such as those on the
soles of the feet or close to nails, may also warrant treatment.5
Because currently available treatments for plantar warts often
fail, future research should not only focus on new treatments,
but also try to identify subgroups of patients who will respond
to specific treatments. Large numbers of HPV types, distributed
over five genera, infect the human skin.10 HPV types belonging
to four of those genera—alphapapillomaviruses,
gammapapillomaviruses, mupapillomaviruses, and
nupapillomaviruses—have been detected in cutaneous warts.
Little is known about the epidemiology and prevalence of these
HPV types that cause common and plantar warts. Reliable
detection and sampling techniques are needed to study the
epidemiology of these HPV infections and have only recently
become available.11 This assay detects and identifies DNA of
all known wart associated HPV types from the
alphapapillomaviruses (HPV types 2, 3, 7, 10, 27, 28, 29, 40,
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43, 57, 77, 91, 94), gammapapillomaviruses (HPV types 4, 65,
95, 48, 50, 60, 88), mupapillomaviruses (HPV types 1 and 63),
and nupapillomaviruses (HPV41), but epidemiological studies
using this technique are not yet available.
Definitive treatment for plantar warts remains elusive. Treatment
with salicylic acid or liquid nitrogen is probably not more
effective than a wait and see policy. Large scale HPV typing
may teach us more about the epidemiology of plantar warts and
which HPV types are preferentially present. HPV specific
treatments that are based on the HPV type in the lesions may
be the way forward. However, future treatments must be safe,
preferably painless, and not increase morbidity.7 This is
especially important, because around two thirds of warts clear
without treatment within two years.
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